Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color doppler flow mapping in chronic dialysis patients
- 30 June 1999
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 33 (6) , 1091-1099
- https://doi.org/10.1016/s0272-6386(99)70146-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Imaging of the parathyroid in chronic renal failure: diagnostic and therapeutic aspectsCurrent Opinion in Nephrology and Hypertension, 1997
- Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: a theoretical approachNephrology Dialysis Transplantation, 1996
- The pathogenesis of parathyroid gland hyperplasia in chronic renal failureKidney International, 1995
- Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patientsKidney International, 1994
- Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid functionKidney International, 1993
- Recent progress in management of secondary hyperparathyroidism of chronic renal failureCurrent Opinion in Nephrology and Hypertension, 1993
- The spectrum of bone disease in end-stage renal failure—An evolving disorderKidney International, 1993
- Diagnosis and treatment of aluminium overload in end-stage renal failure patientsNephrology Dialysis Transplantation, 1993
- Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism.Radiology, 1985
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984